GPSC and other supports for pain management and opioid prescribing

Issue: BCMJ, vol. 59, No. 4, May 2017, Page 218 News

Opioid agonist therapy supports are available through the GPSC and Pharmacare to address pain management and opioid prescribing.

Opioid agonist therapy supports are available through the GPSC and Pharmacare to address pain management and opioid prescribing. These include:

GPSC fee code G14074 (GP Unattached Complex/High Needs Patient Attachment Fee)
This fee compensates for the time, intensity, and complexity of integrating a new patient with high needs, including mental health and substance use patients, into a family physician’s practice. For more information, please refer to the GPSC’s attachment billing guide.[1]

GPSC fee code G14043 (GP Mental Health Planning Fee)
This fee is payable upon the development and documentation of a patient’s mental health plan for patient residents in the community. Patients must have a confirmed Axis I diagnosis of sufficient severity and acuity to warrant the development of a management plan, and both Alcohol Dependency (303) and Substance Abuse (non-nicotine) (304) qualify as Axis I diagnoses. If this fee is billed for a patient with either alcohol or substance abuse issues, all other criteria of the fee must be met. For more information, please refer to the GPSC’s mental health billing guide.[2]

Pharmacare coverage
Effective 1 February 2017, Pharmacare will cover Methadose for maintenance and buprenorphine/naloxone under its Psychiatric Medications Plan (Plan G). By covering these drugs under Plan G, 100% Pharmacare coverage may be available to more individuals with lower incomes. For more information, please refer to:
•    Coverage of Methadose and Bupre-norphine/Naloxone under Plan G[3]
•    Pharmacare Newsletter[4]

As well, doctors can access available supports created by local divisions and the GPSC that are summarized at www.divisionsbc.ca/provincial/painmanagement.

These resources help doctors to manage substance use issues in their own communities, and to comply with opioid prescribing standards[5] announced by the College of Physician and Surgeons of BC in 2016.

References

1.     GPSC. Billing guide – attachment. 2017. Accessed 6 April 2017. www.gpscbc.ca/sites/default/files/uploads/GPSC Billing Guide - Attachment 20170206.pdf.
2.     GPSC. Billing guide – mental health. 2016. Accessed 6 April 2017. www.gpscbc.ca/sites/default/files/uploads/GPSC Billing Guide - Mental Health 20160518.pdf.
3.     Government of BC. Coverage of Methadose and buprenorphine/naloxone under plan G. Accessed 6 April 2017. www2.gov.bc.ca/gov/content/health/health-drug-coverage/pharmacare-for-bc-residents/what-we-cover/drug-coverage/coverage-of-methadose-and-buprenorphine-naloxone-under-plan-g.
4.     Government of BC. BC Pharmacare newsletter, January 18 2017, Edition 17-001. Accessed 6 April 2017. www2.gov.bc.ca/assets/gov/health/health-drug-coverage/pharmacare/newsletters/news17-001.pdf.
5.     College of Physicians and Surgeons of BC. Safe prescribing of drugs with potential for misuse/diversion. Accessed 6 April 2017. www.cpsbc.ca/files/pdf/PSG-Safe-Prescribing.pdf.

. GPSC and other supports for pain management and opioid prescribing. BCMJ, Vol. 59, No. 4, May, 2017, Page(s) 218 - News.


Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply